Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: Adcock Ingram Limited, Address, 1 New Road, Erand Gardens, Midrand, 1685
STOPAYNE TABLETS, tablets.
Pharmaceutical Form |
---|
Tablets. Light green, round biconvex tablets, scored on one side and RIO embossed on the other side. |
Each tablet contains:
Meprobamate 150 mg
Codeine phosphate 8 mg
Paracetamol 320 mg
Caffeine anhydrous 32 mg
Excipients with known effect:
Contains sugar (lactose monohydrate): 1 mg
Contains the colouring agent sunset yellow FCF (E 110)
For full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Caffeine |
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
|
Codeine |
Codeine is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain. |
|
Meprobamate |
Meprobamate is a carbamate with hypnotic, sedative and some muscle relaxant properties. It is used for the short-term treatment of anxiety states, muscle tension and associated conditions where anxiety is present. In therapeutic doses its sedative effect rather than a direct action may be responsible for muscle relaxation. |
|
Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
List of Excipients |
---|
Brilliant blue FCF (E133) |
PVC/PVDC/Aluminium blister strips in an outer carton.
or
White HDPE bottles with white HDPE screw caps in an outer carton.
Pack sizes: 100 or 1 000 tablets.
Not all pack sizes may be marketed.
Adcock Ingram Limited, Address, 1 New Road, Erand Gardens, Midrand, 1685
B 866 (Act 101/1965)
Namibia NS3 14/2.8/0417
Botswana S1 B9300805
Date of registration: 19 November 1986
Drug | Countries | |
---|---|---|
STOPAYNE | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.